Erlotinib is used in the treatment of non-small cell lung cancer and pancreatic cancer.
How Erlotinib works Erlotinib is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are present on the surfaces of lung cancer cells and play a role in regulating their growth. This medication works by binding to the chemical messenger EGFR, thereby inhibiting the cancer signaling pathways mediated by EGFR. This mechanism restricts the further growth of cancer cells.
Common side effects of Erlotinib include acne, conjunctivitis, dry skin, gastrointestinal bleeding, hair follicle inflammation, hair loss, nosebleeds, skin fissures, corneal inflammation, paronychia, and renal insufficiency.